Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P P Tak

Showing results (171-180 of 203) with videos related to

Pageof 21
Sort By:
Annals of the Rheumatic Diseases|March 17, 2007
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agentJ Adriaansen, M Khoury, C J de Cortie, et al.
Clinical Rheumatology|April 9, 2017
Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolismM W Tang, F S van Nierop, F A Koopman, et al.
Scandinavian Journal of Rheumatology|September 3, 2014
E-health to improve work functioning in employees with rheumatoid arthritis in rheumatology practice: a feasibility studyJ L Hoving, I Zoer, M van der Meer, et al.
Annals of the Rheumatic Diseases|August 4, 2010
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activityT Groot Kormelink, J Tekstra, R M Thurlings, et al.
Annals of the Rheumatic Diseases|July 10, 2004
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritisJ van Holten, K Pavelka, J Vencovsky, et al.
Annals of the Rheumatic Diseases|November 27, 2007
Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept studyG A W Bruyn, G Tate, F Caeiro, et al.
Plos One|March 31, 2016
A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis PatientsS C Nair, P M J Welsing, I Y K Choi, et al.
Genes and Immunity|October 12, 2007
Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patientsT C T M van der Pouw Kraan, L G M van Baarsen, C A Wijbrandts, et al.
Rheumatology (Oxford, England)|January 2, 2003
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controlsD R Haynes, E Barg, T N Crotti, et al.
Annals of the Rheumatic Diseases|December 7, 2007
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synoviumC A Wijbrandts, M G W Dijkgraaf, M C Kraan, et al.
Pageof 21

Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Annals of the Rheumatic Diseases|March 17, 2007
Reduction of arthritis following intra-articular administration of an adeno-associated virus serotype 5 expressing a disease-inducible TNF-blocking agentJ Adriaansen, M Khoury, C J de Cortie, et al.
Clinical Rheumatology|April 9, 2017
Single vagus nerve stimulation reduces early postprandial C-peptide levels but not other hormones or postprandial metabolismM W Tang, F S van Nierop, F A Koopman, et al.
Scandinavian Journal of Rheumatology|September 3, 2014
E-health to improve work functioning in employees with rheumatoid arthritis in rheumatology practice: a feasibility studyJ L Hoving, I Zoer, M van der Meer, et al.
Annals of the Rheumatic Diseases|August 4, 2010
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activityT Groot Kormelink, J Tekstra, R M Thurlings, et al.
Annals of the Rheumatic Diseases|July 10, 2004
A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritisJ van Holten, K Pavelka, J Vencovsky, et al.
Annals of the Rheumatic Diseases|November 27, 2007
Everolimus in patients with rheumatoid arthritis receiving concomitant methotrexate: a 3-month, double-blind, randomised, placebo-controlled, parallel-group, proof-of-concept studyG A W Bruyn, G Tate, F Caeiro, et al.
Plos One|March 31, 2016
A Personalized Approach to Biological Therapy Using Prediction of Clinical Response Based on MRP8/14 Serum Complex Levels in Rheumatoid Arthritis PatientsS C Nair, P M J Welsing, I Y K Choi, et al.
Genes and Immunity|October 12, 2007
Expression of a pathogen-response program in peripheral blood cells defines a subgroup of rheumatoid arthritis patientsT C T M van der Pouw Kraan, L G M van Baarsen, C A Wijbrandts, et al.
Rheumatology (Oxford, England)|January 2, 2003
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controlsD R Haynes, E Barg, T N Crotti, et al.
Annals of the Rheumatic Diseases|December 7, 2007
The clinical response to infliximab in rheumatoid arthritis is in part dependent on pretreatment tumour necrosis factor alpha expression in the synoviumC A Wijbrandts, M G W Dijkgraaf, M C Kraan, et al.
Pageof 21